Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Lint

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|September 1, 1999
Enhancement of lectin pathway haemolysis by immunoglobulinsC Suankratay, Y Zhang, D Jones, et al.
Immunology|April 1, 1975
Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factorB McLeod, T F Lint, P Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1977
C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitorsP J Baker, T F Lint, R F Mortensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complementH J Zeitz, R A Zeff, H Gewurz, et al.
Inflammation|December 1, 1988
Changes in respiratory burst activity during human monocyte differentiation in suspension cultureJ M Zeller, J Caliendo, T F Lint, et al.
Journal of Virology|December 1, 1990
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysisG T Spear, B L Sullivan, A L Landay, et al.
Journal of Immunological Methods|December 24, 1986
An enzyme-linked immunoabsorbent assay for the quantitation of the terminal complement complex from cell membranes or in activated human seraM S Gawryl, M T Simon, J L Eatman, et al.
Arthritis and Rheumatism|February 1, 1988
The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosusM S Gawryl, D S Chudwin, P F Langlois, et al.
Arthritis and Rheumatism|January 1, 1978
Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathwayA Gewurz, T F Lint, J L Roberts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 1998
Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathwayC Suankratay, X H Zhang, Y Zhang, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|September 1, 1999
Enhancement of lectin pathway haemolysis by immunoglobulinsC Suankratay, Y Zhang, D Jones, et al.
Immunology|April 1, 1975
Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factorB McLeod, T F Lint, P Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1977
C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitorsP J Baker, T F Lint, R F Mortensen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complementH J Zeitz, R A Zeff, H Gewurz, et al.
Inflammation|December 1, 1988
Changes in respiratory burst activity during human monocyte differentiation in suspension cultureJ M Zeller, J Caliendo, T F Lint, et al.
Journal of Virology|December 1, 1990
Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysisG T Spear, B L Sullivan, A L Landay, et al.
Journal of Immunological Methods|December 24, 1986
An enzyme-linked immunoabsorbent assay for the quantitation of the terminal complement complex from cell membranes or in activated human seraM S Gawryl, M T Simon, J L Eatman, et al.
Arthritis and Rheumatism|February 1, 1988
The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosusM S Gawryl, D S Chudwin, P F Langlois, et al.
Arthritis and Rheumatism|January 1, 1978
Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathwayA Gewurz, T F Lint, J L Roberts, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 1998
Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathwayC Suankratay, X H Zhang, Y Zhang, et al.
Pageof 6